Product correctly added to cart.

discount label
β-Ergocryptinine-d3
View 3D

Biosynth logo

β-Ergocryptinine-d3

CAS: 19467-61-9

Ref. 3D-UAA46761

1mgTo inquire
Estimated delivery in United States, on Wednesday 15 Jan 2025

Product Information

Name:
β-Ergocryptinine-d3
Controlled Product
Synonyms:
  • Ergotaman-3',6',18-trione, 12'-hydroxy-2'-(1-methylethyl)-5'-(1-methylpropyl)-, (5'alpha(S),8alpha)-
Description:

β-Ergocryptinine-d3 is a nitrogen-containing heterocyclic compound with a wide range of biological activities. It has been isolated from natural sources and its chemical structure has been determined using X-ray diffraction and spectroscopic data. This compound has shown significant inhibition against gram-negative bacteria, including Escherichia coli. Additionally, β-Ergocryptinine-d3 exhibits anticancer properties and has been found to have pharmacological activities in K562 and HL-60 cancer cells. Its isolation from natural sources using ethyl acetate extraction or chemical methods makes it a valuable compound for further research into potential therapeutic applications.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
575.7 g/mol
Formula:
C32H41N5O5
Purity:
Min. 95%
Color/Form:
Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-UAA46761 β-Ergocryptinine-d3

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".